Wavelength dependency of the critical flicker-fusion frequency: therapeutic 40 Hz light source in Alzheimer’s disease

Marcus S. Carstensen; Martin W. Thorning-Schmidt; Mikkel Agger; N. Mai Nguyen; Jes Broeng; Troels W. Kjær; Paul Michael Petersen

doi:10.1117/12.2582940

5 March 2021 Wavelength dependency of the critical flicker-fusion frequency: therapeutic 40 Hz light source in Alzheimer’s disease

Marcus S. Carstensen, Martin W. Thorning-Schmidt, Mikkel Agger, N. Mai Nguyen, Jes Broeng, Troels W. Kjær, Paul Michael Petersen

Author Affiliations +

Proceedings Volume 11628, Mechanisms and Techniques in Photodynamic Therapy and Photobiomodulation; 116280A (2021) https://doi.org/10.1117/12.2582940
Event: SPIE BiOS, 2021, Online Only

Abstract

The use of controlled temporal modulated light increased in prominence since the LEDs invention, e.g., in computer monitors and light therapy devices. The benefits of using LEDs compared to old incandescent light bulbs range from environmental load to the precise control of the spectral properties and the ability to accurately control the temporal modulation of the light. The nature of LEDs also allows LED lamps to be switched on and off faster than ordinary incandescent light bulbs. The driver frequency of most LEDs (~25 kHz) is so high that the modulation of firing rates of the retinal neurons cannot time dissolve the flicker at this frequency. But in some cases, the function of the LED is to provide temporal modulation at frequencies much lower, in the range of 24-48 Hz. Knowing the Critical Flicker-Fusion Frequency (CFF), the frequency at which temporally modulated light becomes steady, is therefore important. Potential treatments of Alzheimer’s disease are currently being examined in humans using both stroboscopic and invisible spectral flickering light, using a 40 Hz temporal modulation. Ultimately, the CFF dependency on color, luminance, viewing angle and background lighting needs to be taken into account when designing and developing 40 Hz light sources for potential therapeutic use within the field of Alzheimer's disease. Here, we present a potential benefit of using the staircase method with a 2-alternative forced choice to determine the CFF. Specifically, we show a portable experimental setup that may be used directly to optimize light therapy for patients with Alzheimer’s disease.

Conference Presentation

Citation Download Citation

Marcus S. Carstensen, Martin W. Thorning-Schmidt, Mikkel Agger, N. Mai Nguyen, Jes Broeng, Troels W. Kjær, and Paul Michael Petersen "Wavelength dependency of the critical flicker-fusion frequency: therapeutic 40 Hz light source in Alzheimer’s disease", Proc. SPIE 11628, Mechanisms and Techniques in Photodynamic Therapy and Photobiomodulation, 116280A (5 March 2021); https://doi.org/10.1117/12.2582940

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available